1. A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe
- Author
-
Aleksandar Potkonjak, Muriel Vayssier-Taussat, Sally J. Cutler, Herve Zeller, Ioana Adriana Matei, Agustín Estrada-Peña, Andrei Daniel Mihalca, Lucía Varela-Castro, Department of Parasitology and Parasitic Diseases, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj Napoca -University of Agricultural Sciences and Veterinary Medicine Cluj Napoca, Department of Animal Health, University of Zaragoza - Universidad de Zaragoza [Zaragoza]-University of Zaragoza - Universidad de Zaragoza [Zaragoza], School of Health, Sport & Bioscience, University of East London (UEL), Biologie du Développement et Reproduction (BDR), École nationale vétérinaire d'Alfort (ENVA)-Institut National de la Recherche Agronomique (INRA), Animal Health Department, Bizkaia Science and Technology Park, Instituto Vasco de Investigación y Desarrollo Agrario [Derio] (NEIKER)-Instituto Vasco de Investigación y Desarrollo Agrario [Derio] (NEIKER), Department of Veterinary Medicine, Faculty of Agriculture, University of Novi Sad-University of Novi Sad, Emerging and Vector-borne Diseases Programme, European Centre for Disease Prevention and Control (ECDC), and ECDC Project OJ/24/04/2014-PROC/2014/013Ministry of Research and Innovation through Program 1-Development of the National Research and Development System, Subprogram 1.2-Institutional Performance-Projects for Financing the Excellence in CDI 37PFE/06.11.2018
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Anaplasmosis ,Ixodes ricinus ,Clinical signs ,Human granulocytic anaplasmosis ,030106 microbiology ,030231 tropical medicine ,Disease ,Review ,Tick ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Epidemiology ,parasitic diseases ,Diagnosis ,medicine ,Prevalence ,Transmission ,Animals ,Humans ,lcsh:RC109-216 ,Horses ,HGA ,biology ,Ixodes ,Transmission (medicine) ,biology.organism_classification ,medicine.disease ,bacterial infections and mycoses ,Anaplasma phagocytophilum ,3. Good health ,Anti-Bacterial Agents ,Europe ,[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology ,Infectious Diseases ,Vector (epidemiology) ,Parasitology - Abstract
Anaplasma phagocytophilum is the agent of tick-borne fever, equine, canine and human granulocytic anaplasmosis. The common route of A. phagocytophilum transmission is through a tick bite, the main vector in Europe being Ixodes ricinus. Despite the apparently ubiquitous presence of the pathogen A. phagocytophilum in ticks and various wild and domestic animals from Europe, up to date published clinical cases of human granulocytic anaplasmosis (HGA) remain rare compared to the worldwide status. It is unclear if this reflects the epidemiological dynamics of the human infection in Europe or if the disease is underdiagnosed or underreported. Epidemiologic studies in Europe have suggested an increased occupational risk of infection for forestry workers, hunters, veterinarians, and farmers with a tick-bite history and living in endemic areas. Although the overall genetic diversity of A. phagocytophilum in Europe is higher than in the USA, the strains responsible for the human infections are related on both continents. However, the study of the genetic variability and assessment of the difference of pathogenicity and infectivity between strains to various hosts has been insufficiently explored to date. Most of the European HGA cases presented as a mild infection, common clinical signs being pyrexia, headache, myalgia and arthralgia. The diagnosis of HGA in the USA was recommended to be based on clinical signs and the patient’s history and later confirmed using specialized laboratory tests. However, in Europe since the majority of cases are presenting as mild infection, laboratory tests may be performed before the treatment in order to avoid antibiotic overuse. The drug of choice for HGA is doxycycline and because of potential for serious complication the treatment should be instituted on clinical suspicion alone.
- Published
- 2019
- Full Text
- View/download PDF